Literature DB >> 10311893

Medicare capitation payments to HMOs in light of regression toward the mean in health care costs.

W P Welch.   

Abstract

The literature suggests four basic "facts" about biased selection in PGPs: First, the well disproportionally enroll in PGPs. Second, for a group defined according to low expenditure, expenditure regresses toward the mean. Whether this is applicable to PGPs is unclear. Third, the well disproportionally disenroll from PGPs. Finally, although more evidence is needed, there appears to be little or no bias in PGP enrollee populations. This paper presents a framework that unifies these patterns. Based on these findings, this paper draws several conclusions that are relevant to Medicare capitation payments to HMOs; First, attempts to increase the sophistication of the AAPCC to compensate for biased selection should focus on predictors of the permanent component of expenditures instead of using past expenditures as a predictor. One can explain no more than 20 percent of the variance in such equations. Second, because of regression toward the mean, there are several interpretations of biased-enrollment estimates based on preenrollment data. The issue of these interpretations is unlikely to be resolved without a randomized experiment, although research with nonexperimental data could be useful. Third, due to the probable decay in PGPs' preferential selection, for rollovers there may be little biased selection, and for switchers the length of enrollment might be included in the AAPCC. Fourth, the adequacy of an AAPCC depends, in part, on whether biased selection results from consumer behavior or HMO behavior. Each of these conclusions suggests a research topic that should have priority: first, finding predictors of the permanent component of expenditure, thus increasing the percentage of the variance explained; second, testing the socioeconomic characteristics model of biased enrollment; third, measuring the speed at which the preferential selection of PGPs declines; fourth, investigating HMOs' ability to "select" enrollees.

Entities:  

Mesh:

Year:  1985        PMID: 10311893

Source DB:  PubMed          Journal:  Adv Health Econ Health Serv Res        ISSN: 0731-2199


  14 in total

1.  Understanding biased selection in Medicare HMOs.

Authors:  Michelle M Mello; Sally C Stearns; Edward C Norton; Thomas C Ricketts
Journal:  Health Serv Res       Date:  2003-06       Impact factor: 3.402

2.  Multiple prior years of health expenditures and Medicare health plan choice.

Authors:  Matthew L Maciejewski; Bryan Dowd; Heidi O'Connor
Journal:  Int J Health Care Finance Econ       Date:  2004-09

Review 3.  Risk adjustment for a children's capitation rate.

Authors:  J P Newhouse; E M Sloss; W G Manning; E B Keeler
Journal:  Health Care Financ Rev       Date:  1993

4.  Analysis of underwriting factors for AAPCC (adjusted average per capita cost).

Authors:  K G Manton; E Stallard
Journal:  Health Care Financ Rev       Date:  1992

5.  The cost of relapse and the predictors of relapse in the treatment of schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; David Salkever; Eric P Slade; Xiaomei Peng; Robert R Conley
Journal:  BMC Psychiatry       Date:  2010-01-07       Impact factor: 3.630

Review 6.  Capitation payment: using predictors for medical utilization to adjust rates.

Authors:  A M Epstein; E J Cumella
Journal:  Health Care Financ Rev       Date:  1988

7.  Trends in the health status of medicare risk contract enrollees.

Authors:  Gerald Riley; Carlos Zarabozo
Journal:  Health Care Financ Rev       Date:  2006

8.  Adjusting capitation rates using objective health measures and prior utilization.

Authors:  J P Newhouse; W G Manning; E B Keeler; E M Sloss
Journal:  Health Care Financ Rev       Date:  1989

9.  Medicare reimbursement and regression to the mean.

Authors:  J C Beebe
Journal:  Health Care Financ Rev       Date:  1988

10.  Managed competition in health care and the unfinished agenda.

Authors:  A C Enthoven
Journal:  Health Care Financ Rev       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.